Total number of patients |
73 |
Age (Mean, Years) |
54.88 (18.8-79.67) |
Gender (Male) |
52 (71.2%) |
Smokers (Yes) |
54 (43.8%) |
T Classification |
|
1
|
10 (13.7%)
|
2
|
16 (21.9%)
|
3
|
16 (21.9%)
|
4
|
31 (42.5%)
|
N Classification |
|
0
|
15 (20.5%)
|
1
|
29 (39.7%)
|
2
|
21 (28.8%)
|
3
|
8 (11%)
|
M Classification |
|
0
|
67 (93.2%)
|
1
|
5 (6.8%)
|
Stage |
|
1
|
2 (2.7%)
|
2
|
14 (19.2%)
|
3
|
23 (31.5%)
|
4a
|
29 (39.7%)
|
4b
|
5 (6.8%)
|
EBV |
|
Positive
|
38 (52.1%)
|
Negative
|
35 (47.9%)
|
WHO Classification
1 – Keratinizing
2 – Non-Keratinizing Differentiated
3 – Non-Keratinizing Undifferentiated
|
2 (2.7%)
32 (43.8%)
39 (53.4%)
|
MEE |
|
At presentation
|
14 (19.18%)
|
Post irradiation (Excluding MEE at presentation)
|
18 (24.66%)
|
Radiation type |
|
IMRT
|
56 (76.7%)
|
EBR
|
17 (23.3%)
|
Follow-up time (Median, Years) |
4.98 (1-16.8) |